SABRA HEALTH CARE ($SBRA) posted quarterly earnings results for Q1 2026 on Wednesday, April 29th. The company reported earnings of $0.39 per share, beating estimates of $0.17 by $0.22. The company also reported revenue of $221,750,000, beating estimates of $207,311,603 by $14,438,397.
You can see Quiver Quantitative's $SBRA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
SABRA HEALTH CARE Insider Trading Activity
SABRA HEALTH CARE insiders have traded $SBRA stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $SBRA stock by insiders over the last 6 months:
- JESSICA FLORES (Executive VP & CAO) sold 15,231 shares for an estimated $302,487
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
SABRA HEALTH CARE Hedge Fund Activity
We have seen 226 institutional investors add shares of SABRA HEALTH CARE stock to their portfolio, and 187 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRINCIPAL FINANCIAL GROUP INC added 4,431,897 shares (+21.6%) to their portfolio in Q4 2025, for an estimated $83,940,129
- LASALLE INVESTMENT MANAGEMENT SECURITIES LLC added 3,534,217 shares (+inf%) to their portfolio in Q4 2025, for an estimated $66,938,069
- SUMITOMO MITSUI TRUST GROUP, INC. added 2,736,993 shares (+1019.8%) to their portfolio in Q4 2025, for an estimated $51,838,647
- CENTERSQUARE INVESTMENT MANAGEMENT LLC added 2,654,480 shares (+inf%) to their portfolio in Q4 2025, for an estimated $50,275,851
- BANK OF MONTREAL /CAN/ removed 2,449,294 shares (-87.9%) from their portfolio in Q4 2025, for an estimated $46,389,628
- FREESTONE GROVE PARTNERS LP added 1,840,635 shares (+inf%) to their portfolio in Q4 2025, for an estimated $34,861,626
- MILLENNIUM MANAGEMENT LLC added 1,771,342 shares (+197.5%) to their portfolio in Q4 2025, for an estimated $33,549,217
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
SABRA HEALTH CARE Analyst Ratings
Wall Street analysts have issued reports on $SBRA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 11/25/2025
To track analyst ratings and price targets for SABRA HEALTH CARE, check out Quiver Quantitative's $SBRA forecast page.
SABRA HEALTH CARE Price Targets
Multiple analysts have issued price targets for $SBRA recently. We have seen 7 analysts offer price targets for $SBRA in the last 6 months, with a median target of $22.0.
Here are some recent targets:
- John Kilichowski from Wells Fargo set a target price of $22.0 on 03/26/2026
- Michael Lewis from Truist Securities set a target price of $22.0 on 03/13/2026
- Nicholas Yulico from Scotiabank set a target price of $21.0 on 03/02/2026
- Michael Goldsmith from UBS set a target price of $21.0 on 02/19/2026
- Aaron Hecht from Citizens set a target price of $23.0 on 02/18/2026
- Nick Joseph from Citigroup set a target price of $24.0 on 02/18/2026
- Richard Anderson from Cantor Fitzgerald set a target price of $21.0 on 02/17/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
